Read article – Quotes Elizabeth Talbot, professor of medicine, in an article about the quarantine measures being taken in China to curb the spread of coronavirus. Chinese authorities have indefinitely barred 50 million people from traveling and advised them to stay home to contain the rapidly spreading virus. “We would almost certainly not do any quarantine on the scope that China is doing now,” Talbot said of the United States’ methods for handling disease outbreaks. “We have a different cultural acceptance of restriction of our rights, and quarantine always bumps up against that.”
Articles by: Geisel Communications
‘Small’ Tactics to Counter Big Pharma’s Influence on Medication Overload – STAT
Read article – Highlights the “Drug Facts” box—a standardized, single-page format for conveying drug effectiveness and risk of harm—developed by researchers Steven Woloshin, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, and the late Geisel professor Lisa Schwartz.
Drugs Cost More When Manufacturers Sell Directly to Physicians, Study Says – Becker’s Hospital Review
Read article – Features a study conducted by researchers at Dartmouth that found that drugmakers promoting their drugs directly to physicians affect prescribing quality and can raise drug prices, but the practice is more commonplace in smaller health systems with fewer physicians.
FDA Approves Ubrogepant for Acute Treatment of Migraine What the Data Show – Neurology Today
Read article – Quotes Stewart Tepper, professor of neurology, in an article about how a new oral agent, ubrogepant, was approved by the U.S. Food and Drug Administration for treatment of acute migraine. “The advantage of this drug and of its cousin (rimegepant) is the side effects are really minimal,” said Tepper.
Lessons from my first patient – Boston Globe
Read article – An article by Sathvik Namburar, Geisel ’22, on his experience during anatomy dissections in which he thought often about his patient’s life.
2020 Atlanta 500: Education & Healthcare – Atlanta
Read article – Highlights Anne Schuchat, MED ’84, principal deputy director at the Centers for Disease Control and Prevention, and Walter J. Curran Jr. ’73, executive director of the Winship Cancer Institute of Emory University, in Atlanta Magazine’s list of Atlanta’s 500 most powerful people.
Researchers find VISTA molecule silences immune system against cancer – Drug Target Review
Read article – An article on a new study showing that the VISTA molecule stops the immune system from responding to self-antigens quotes Randolph Noelle, professor of microbiology and immunology. “We have learned that keeping your immune system quiet is a challenging and very active process,” Noelle said.
This Immune Checkpoint Could Be a New Target Against Cancer, Autoimmune Diseases – Fierce Biotech
Read article – Quotes Randolph Noelle, professor of microbiology and immunology, in an article about a study he conducted that found an immune checkpoint that could also serve as a therapeutic target for cancer and autoimmune diseases.
U.S. Prices for Healthcare Services Far Outpace Peer Nations – Forbes
Read article – Briefly cites data from the Dartmouth Atlas Project that shows there is a persistent unexplained variance in hospital costs intra-regionally.
Can We Design Our Way to Better Health? Some Vermonters Think So – Seven Days
Read article – Quotes James Rustad, assistant professor of psychiatry, in an article about user-experience designer Katie McCurdy and her startup Pictal Health, which helps people suffering from chronic illness create visual depictions of their symptoms to share with their doctor. Rustad says he’s interested in pursuing long-term research on the effects of design work such as McCurdy’s. He treated 10 veterans who had worked with McCurdy to map their health problems. “I think the patients found the process of working with her quite therapeutic,” Rustad said. “I thought she was really able to capture the breadth and depth of their life experience.”